Expression and cellular distribution of claudin-1, a tight junction protein, is dysregulated in colon cancer and its overexpression in colon cancer cells induced dedifferentiation and increased invasion. However, the molecular mechanism(s) underlying dysregulated claudin-1 expression in colon cancer remains poorly understood. Histone deacetylase (HDAC)-dependent histone acetylation is an important mechanism of the regulation of cancer-related genes and inhibition of HDACs induces epithelial differentiation and decreased invasion. Therefore, in this study, we examined the role of HDAC-dependent epigenetic regulation of claudin-1 in colon cancer. In this study, we show that sodium butyrate and Trichostatin A (TSA), two structurally different and widely used HDAC inhibitors, inhibited claudin-1 expression in multiple colon cancer cell lines. Further studies revealed modulation of claudin-1 mRNA stability by its 3 0 -UTR as the major mechanism underlying HDAC-dependent claudin-1 expression. In addition, overexpression of claudin-1 abrogated the TSA-induced inhibition of invasion in colon cancer cells suggesting functional crosstalk. Analysis of mRNA expression in colon cancer patients, showed a similar pattern of increase in claudin-1 and HDAC-2 mRNA expression throughout all stages of colon cancer. Inhibition of claudin-1 expression by HDAC-2-specific small interfering RNA further supported the role of HDAC-2 in this regulation. Taken together, we report a novel post-transcriptional regulation of claudin-1 expression in colon cancer cells and further show a functional correlation between claudin-1 expression and TSA-mediated regulation of invasion. As HDAC inhibitors are considered to be promising anticancer drugs, these new findings will have implications in both laboratory and clinical settings.
Introduction
Efficient transcription requires concerted actions of multiple protein factors and post-translational modifications of histones including acetylation, methylation, ubiquitination and adenosine diphosphate ribosylation. The best understood histone modification is acetylation of core histones and is maintained by the opposing activities of histone acetylases and histone deacetylases (HDACs). Histone deacetylase inhibitors (HDACIs) have been noted for their ability to induce cell cycle arrest, differentiation and apoptosis in numerous cancer cell types including colon cancer (Dokmanovic and Marks, 2005) . In addition, HDACIs have also shown signs of efficacy in phase I and phase II clinical trials (Minucci and Pelicci, 2006) . However, the molecular mechanism(s) underlying HDACI actions remain incompletely understood. Therefore, it is imperative that we gain a more thorough understanding of the effect of these agents on intracellular targets.
Tumor invasion and metastasis with loss of functional tight junctions are key characteristics of the aggressive cancer phenotype and metastasis is a major cause of cancer-related death. The claudin family of proteins are the major constituent of tight junctions, are expressed in a tissue-specific manner and appears to be controlled differently in cancers from distinct tissues.
We have earlier observed dysregulated claudin-1 expression in colon cancer. We have also shown a positive correlation of claudin-1 expression with colon tumor progression, invasion and metastasis (Dhawan et al., 2005) . Other studies have shown epigenetic regulation of specific claudin family members (Honda et al., 2007; Nishikiori et al., 2008) in addition to occludin and its correlation with tumorigenicity of cancer cells (Osanai et al., 2007b) . HDACI suppress activities of multiple HDACs that lead to increased histone acetylation and thus modulate expression of specific genes involved in growth arrest, differentiation and apoptosis. Inhibition of claudin-1 expression in colon cancer cells induces similar morphological and metabolic changes (Dhawan et al., 2005; Shiou et al., 2007) . Therefore, we hypothesized a role for HDACs in the regulation of claudin-1 in colon cancer.
In this study, we report HDAC-dependent regulation of claudin-1 expression in colon cancer with change in mRNA stability as the principal mechanism underlying this regulation. We further provide data supporting a functional correlation between claudin-1 expression and the anti-invasive effects of HDACI supporting claudin-1 as one of the target molecules affected on HDAC inhibition.
Results and discussion
HDACIs decreased claudin-1 steady-state mRNA and protein levels in colon cancer cells To test our hypothesis, we exposed multiple claudin-1 expressing colon cancer cells (SW480, SW620 and DLD-1) to increasing concentrations of sodium butyrate (NaB; 0, 1, 2.5, 5 and 10 mM), a known HDACI. Untreated and DMSO-treated cells served as controls. As shown in Figure 1a , upper panel immunoblot analysis using total cell lysates showed a dose-dependent decrease in claudin-1 expression in response to increasing concentrations of NaB in SW480 and SW620 cells. In contrast, E-cadherin expression, known to be increased on HDAC inhibition (Wu et al., 2007) was used as positive control. We further determined effects of increasing concentration of Tricostatin-A (TSA, 0, 50, 100, 200 and 500 ng/ml), a robust and specific inhibitor of class I and II HDACs. Similar to NaB, TSA treatment resulted in a dose-dependent decrease in claudin-1 expression in SW480 and SW620 cells ( Figure 1a , lower panel). In the same samples, claudin-4 expression was largely unaltered (Figure 1a ) whereas expression of claudin-2, yet another claudin family member, increased in a dose-dependent manner similar to E-cadherin expression thus confirming the specificity of regulation (data not shown; communicated elsewhere). Similar results were obtained in DLD-1 cells (data not shown).
To confirm that the HDACIs indeed functioned as expected, we determined expression of acetyl histone H3. Indeed, exposure to either NaB or TSA resulted in accumulation of acetylated histones H3 in SW480 and SW620 cell lines (Figure 1a , lower panel). Together, these findings suggested a role of HDACs in the regulation of claudin-1 expression in colon cancer.
We further examined whether this HDACI-dependent decrease in claudin-1 expression was through the regulation of mRNA expression. Quantitative reverse transcription-PCR (Figure 1b ) and real-time quantitative PCR (Figure 1c) were carried out using gene-specific primers. As shown in Figures 1b and c , similar to the protein levels, claudin-1 mRNA expression was markedly decreased in both NaB-and TSA-treated samples. In contrast, mRNA levels of E-cadherin (Figure 1b) increased on treatment with HDACI whereas claudin-4 mRNA expression remains largely unchanged (Figure 1c) . A similar decrease in claudin-1 mRNA and protein expression suggested a possible HDACI-dependent transcriptional downregulation of claudin-1 expression.
HDACI-dependent decrease in claudin-1 steady-state mRNA levels involved changes in claudin-1 transcription and mRNA stability A role of HDAC-dependent deacetylation in the regulation of mRNA transcription is reported (Chavey et al., 2008; Liu et al., 2008) . Furthermore, transcription of certain claudin family members including claudin-3, -4 and -6 is regulated through epigenetic processes (for example, acetylation of critical promoter region (Abuazza et al., 2006; Honda et al., 2006 Honda et al., , 2007 Osanai et al., 2007a) ). To determine a role of HDACs in the transcriptional regulation of claudin-1 expression, we examined effects of HDACI on claudin-1 promoter activity. A human claudin-1 promoter (-1160 to þ 160)-based luciferase reporter construct described earlier (Shiou et al., 2007) and referred to as pGL3/-1.2Cld-1 was used. The SW480 and SW620 cells were transiently transfected with pGL3/-1.2Cld-1 or pGL3-Basic (vector alone) constructs, along with a reference reporter plasmid. Four hours after transfection, cells were exposed to 200 ng/ml of TSA for 36 h. Samples were collected post-TSA treatment and luciferase reporter activity was determined. Findings from multiple experiments showed a modest decrease of 15-20% as compared with control in claudin-1 promoter activity after TSA treatment (Figure 2a ). An increase (2.5-fold versus control) in E- Figure 1 Histone deacetylase (HDAC) inhibitors decrease the expression of claudin-1. (a) Equal amounts of total protein (25 mg) from SW480 and SW620 cell lines (treated with increasing concentration of sodium butyrate (NaB) or Trichostatin A (TSA) (SigmaAldrich Inc.) for 36 h) were immunoblotted with claudin-1, claudin-4 (Invitrogen), E-cadherin (BD Biosciences) or actin antibody (upper and middle panel). Same samples were also immunoblotted with acetyl histone H3 and histone H3 (Cell Signaling) to confirm the specificity of inhibitors (lower panel). Blots shown are representative of three independent experiments. (b) HDAC inhibitor decreases the claudin-1 levels at the RNA levels. The SW480 and SW620 cells were treated with HDAC inhibitors for 36 h. Total RNA were extracted using TRIzol according to manufacturer's instructions and subjected to semiquantitative reverse transcription-PCR (RT-PCR). Primers for actin were used as internal control in the same reaction. Data represent from four independently replicated experiments. (c) Total RNA was extracted from cells using Trizol (Invitrogen, Carlsbad, CA, USA) according to the protocol provided by the manufacturer. Total RNA (300 ng) of each sample (group) was reverse transcribed using the SuperScript III reverse transcriptase (RT) with gene-specific primers. The primers used in the experiments were sense 5 0 -TCACTCCCAGGAGGATGC-3 0 and anti-sense 5 0 -GGCAGATCCAGTGCAAAGTC-3 0 for claudin-1; sense 5 0 -ATAAAGCCAGTCCTGATGCG-3 0 and anti-sense 5 0 -TAACTGCTCAACCTGTCCCC-3 0 for claudin-4. Reverse transcription was performed by using dNTPs with specific primers at 65 1C for 5 min, 50 1C for 20 min, followed by 10 min at 95 1C to inactivate enzymes. For real-time PCR complementary DNA was synthesized and PCR was carried out using SYBR PCR master kit (AB Biosystems). PCR was carried out in triplicates for each gene being validated. For each individual well, fluorescence curves were log transformed and the slope of the logarithmic portion of the reaction was extracted to determine efficiency. Ct values and efficiency were then used according to the methods of Schefe et al. (2006) to calculate the fold change. the transcriptional regulation because they could not be well suited for the identification of regulatory elements mediating the TSA effects as the chromatin configuration might not be physiological. Furthermore, histone acetylation is critical component of chromatin remodeling and transcriptional regulation. Studies are currently underway to define the mechanism of potential transcriptional regulation of claudin-1 by HDAC inhibitors.
HDACI decreases claudin-1 expression through modulation of mRNA stability In addition to being transcriptional activators, HDACIs are also involved in the post-transcriptional regulation (Yamamichi et al., 2005; Pryzbylkowski et al., 2008) and acetylation of cytoplasmic proteins. Therefore, we further examined effects of HDACI on possible changes in claudin-1 mRNA stability.
To determine changes in claudin-1 mRNA stability, we blocked de novo mRNA transcription using actinomycin D (10 mg/ml), an inhibitor of mRNA transcription. SW480 or SW620 cells were exposed to either actinomycin D (10 mg/ml) or TSA or actinomycin D þ TSA in which actinomycin D was added 4 h after TSA treatment. Samples were collected at 0, 4, 8, 16, 24 and 36 h after actinomycin D treatment. The mRNA expression levels were determined using gene-specific primers and real-time quantitative PCR.
As shown in Figure 2b , results from the cells exposed to actinomycin D alone showed half-life of claudin-1 mRNA in SW480 cells to be B18 h, whereas the half-life after combined treatment of TSA and actinomycin D was B7.5 h. Similar findings were obtained from the use of SW620 cells wherein the half-life of claudin-1 mRNA was B20 h after actinomycin D treatment whereas combined exposure to TSA and actinomycin D decreased it to B9 h (Figure 2c ). Taken together, these findings suggested change in mRNA stability as the principal mechanism underlying HDACI-dependent decreases in claudin-1 expression in colon cancer cells.
The 3
0 -UTR of claudin-1 is important for its mRNA stability An important role of 3 0 -UTR in the regulation of mRNA stability is reported. This regulation primarily involves interaction of cis-elements in the 3 0 -UTR of a gene with specific trans-acting factors. In addition, the presence of a long 3 0 -UTR is frequently indicative of post-translational regulation of gene expression through modulation of mRNA stability (Pesole et al., 2001) . It should be noted that claudin-1 possesses a long (B2.3 kb) 3 0 -UTR. Therefore, we further determined the importance of the claudin-1 3 0 -UTR in TSAdependent mRNA degradation. We used SW480 Epigenetic regulation of claudin-1 expression M Krishnan et al mRNA expression was observed in SW480 claudinÀ1 cells in response to TSA treatment (Figure 3a) . In addition, the rate of mRNA decay in SW480 claudinÀ1 cells (t1/2 ¼ 19 h) was relatively slower compared with the parental SW480 cells (t1/2 ¼ 8 h) on combined treatment of TSA and actinomycin D.
To further confirm the role of 3 0 -UTR of claudin-1 mRNA, we used luciferase reporter constructs in which claudin-1 3 0 -UTR regions (2650-3370, fragment 1 or 3121-3370, fragment 2) were inserted into the 3 0 -UTR of luciferase gene. Transfection using different concentrations (0.5 and 1.0 mg of above constructs) was carried out in SW480 and SW620 cells wherein pGL3-vector construct served as a control. As shown in Figure 3b , a significant reduction in a dose-dependent manner in the promoter activity was observed as compared with the parental pGL3 control. Together, these results showed that the 3 0 -UTR of claudin-1 mRNA inhibits the expression of a heterologous reporter gene in colon cancer. The above studies provide strong support for a putative role of 3 0 -UTR in the regulation of claudin-1 mRNA stability, however, more definitive studies including identification and characterization of crucial claudin-1 stabilization sequences/proteins in the 3 0 -UTR are required and are currently under way.
Overexpression of claudin-1 attenuated Trichostatin A-induced decreases in invasion
We further determined functional significance of HDACIdependent decreases in claudin-1 expression. In colon cancer cells, claudin-1 expression is positively associated with invasion and metastasis (Dhawan et al., 2005) . By contrast, exposure to HDACI including TSA or NaB decreases invasion (Wu et al., 2007) . We first confirmed that this is also true in our cell model by treating SW620 cells with TSA (Figure 3c ). Indeed as shown in Figure 3c , TSA treatment resulted in a dose-dependent decrease in invasion. Therefore, we next asked whether overexpression of claudin-1 expression would effectively abrogate or significantly reduce the effect of TSA on cell invasion.
As SW620 cells express high levels of claudin-1, we overexpressed Claudin-1 in SW480 cells with low levels of endogenous claudin-1. SW480 and two different clones of SW480 claudinÀ1 cells were subjected to identical treatments of TSA, 200 ng/ml (36 h) as before and effects on cell invasion were observed. As expected, TSA treatment resulted in significant decreases in cell invasion in control cells. However, TSA-treatment failed to induce a similar level of decreased invasion in SW480 claudinÀ1 cells (Figure 3d ). These findings support a functional role of claudin-1 expression in TSA-induced cell invasion and suggest a pivotal role of claudin-1 protein in the anticancer effects induced by HDAC inhibitors.
Correlation between HDAC-2 and claudin-1 expression in colon cancer Similar to claudin-1, HDAC-1, -2 and -3 are upregulated in colon cancer. Therefore, we used two clinical and genomic databases (representing patients from the Moffitt Cancer Center in Tampa, FL, USA and the Vanderbilt Medical Center, Nashville, TN, USA) to examine a potential correlation in the expression of HDACs and claudin-1 in colorectal cancer. On preliminary analysis, comparing colon cancer tissues versus adenoma tissues in the Vanderbilt Medical Center data set, we noted increased expression of claudin-1 and HDAC-2 in colon cancer patients while we could not observe a similar trend of claudin-1 expression with HDAC-1 or HDAC-3 expression (data not shown). Among HDACs, the specific expression of HDAC2 is higher in human colon cancer samples and cell lines (Zhu et al., 2004; Godman et al., 2008) . In addition, HDAC-2 levels are upregulated in ApcMin/ þ mice (Zhu et al., 2004; Godman et al., 2008) . It should be noted that claudin-1 expression is markedly increased and mislocalized in adenomas from ApcMin/ þ mice compared with normal controls (Dhawan et al., 2005) . Indeed, when we analysed the microarray data from the larger Moffitt Cancer Center data set that represents a total of 205 patient samples (n ¼ 10 normal adjacent colonic tissues and n ¼ 195 colorectal cancer tissues (stages I-IV)), a significant increase in claudin-1 expression across all stages compared with normal adjacent colonic tissue was observed (Po0.001, Figure 4a ). In addition, HDAC-2 expression was significantly upregulated across all stages of colorectal cancer compared with normal colonic tissue (Po0.001, Figure 4a ). Together, our data support the potential coordinate regulation of claudin-1 and HDAC-2 expression in colorectal cancer progression.
To further test the direct dependence of claudin-1 expression on HDAC-2, we silenced HDAC-2 expression in cell models of our study. Both SW480 and SW620 cell lines were transfected using commercially available human HDAC-2-specific small interfering RNAs (siRNAs) or control siRNA and effect on claudin-1 expression was determined. As shown in Figure 4b , immunoblot analysis confirmed effective silencing of HDAC-2 expression in both cell lines after transient transfections with respective siRNAs while there was no change in HDAC-3 expression. In addition, in both cell lines, inhibition of HDAC-2 expression inhibited claudin-1 expression. As expected, claudin-4 expression remained unaltered in the same cell lysates. To further confirm the specificity of this HDAC-2-mediated claudin-1 inhibition, we inhibited HDAC-6 in the same cells. As shown in Figure 4c , inhibition of HDAC-6 using two different siRNAs had no effect on claudin-1 expression. Taken together, these findings further supported our initial hypothesis regarding a role of HDACs in the regulation of claudin-1 expression in colon cancer cells and confirmed the central role of HDAC-2 in particular in this regulation.
Overall, in this report, we show a novel role of HDAC inhibitors in the regulation of claudin-1 expression in colon cancer cells through the regulation of mRNA stability by its 3 0 -UTR. In addition, our findings support a functional cross-talk between HDAC and claudin-1 expression in the regulation of cell invasion. Further investigations are needed to clearly understand the details of HDACI effects on claudin-1 regulation and are currently underway. Findings from our studies have the potential to provide the necessary insight into the mechanism of anticancer effects as well as to improve the therapeutic efficacy of HDAC inhibitors.
Materials and methods

Plasmids and reagents
The antibodies against claudin-1 and -4, were from Invitrogen (San Francisco, CA, USA), and E-cadherin was from BD Biosciences (San Jose, CA, USA). Anti-HDAC -2, -3 antibodies and NaB were purchased from Upstate (NY, USA). claudinÀ1 cells at 70-80% confluence on six-well plates were treated with either Trichostatin A (TSA) alone or actinomycin D alone for different time points, or with TSA (200 ng/ml) for 4 h followed by treatment with 10 mg/ml of actinomycin D, transcription inhibitor. The samples for RNA analysis were then collected at 0, 4, 8, 16, 24 and 36 h after actinomycin D treatment. Total RNA was extracted using the Trizol reagent. The densitometric analysis was carried out and actin was used for normalization. Data are representative of three separate experiments. (b) SW480 and SW620 parental cells were transiently cotransfected with pGL3, pGL3/-fragment 1 (2650-3370) and fragment 2 (3121-3370), constructs as indicated concentration along with a reference reporter construct (phRL-TK). Forty-eight hours later, cells were lysed, and luciferase activity in lysates was measured. Mean of three independent experiments with s.d. and shown in percentage change (pGL3 taken as 100%). (c) Effect of claudin-1 on TSA-mediated invasion. SW620 cells were plated in collagen coated (100 mg/ml) transwells (100 000 cells per transwell) and left for overnight. TSA was added in increasing concentration for 48 h after which invasive cell numbers were scored. Each invasion assay was performed in triplicate and each bar represents the mean ± s.d. of three experiments. (d) SW480 cells and SW480 claudinÀ1 cells were plated in collagen coated (100 mg/ml) transwells (100 000 cells per transwell) and left for overnight. TSA was added to the lower chamber in increasing concentration for 48 h after which invasive cell numbers were scored. Each invasion assay was performed in triplicate and each bar represents the mean±s.d. of three experiments. Fresh tissue specimens from all surgically resected colorectal cancers and endoscopically biopsied rectal cancers were submitted to Surgical Pathology on removal and a representative section of tumor was immediately flash frozen in liquid nitrogen, transported to the laboratory and stored at À80 1C until used for RNA isolation. RNA was purified using the RNeasy kit from Qiagen (Valencia, CA, USA) according to manufacturer protocol. RNA was eluted with 10 m MTris/DEPC H2O at pH 8.0, and samples were submitted to the Vanderbilt Microarray Shared Resource. The raw expression data (cel files) were obtained and converted to expression values using the Affy function in R (www.bioconductor.org). The normalized expression data were analysed for adenomas, normal adjacent colon tissue and American Joint Commission on Cancer stages 1-4 adenocarcinoma in the Vanderbilt and Moffitt data sets. To compare the expression level of each probe between the adenoma, normal tissue and different stages of tumors, the Mann-Whitney tests were conducted and exact P-values were reported because of small sample size and data from the Moffitt patients is shown. (b) Effect of HDAC-2 silencing in colon cancer cells. The SW480 and SW620 cells were seeded into six-well plates and grown overnight followed by transfection with HDAC-2 along with control small interfering RNA (siRNA) (Dharmacon Biotechnology) under serum free condition. After 24 h of transfection, 3 Â serum was added and kept for another 36 h. The cells were lysed and used for immunoblot analysis. Protein levels of HDAC-2, HDAC-3, claudin-1 and claudin-4 were determined by western blot. Blots shown are representative of three independent experiments. (c) Effect of HDAC-6 silencing in SW480 colon cancer cells. The SW480 cells were seeded into six-well plates and grown overnight followed by transfection with HDAC-6 siRNA along with control siRNA (Dharmacon Biotechnology ) under serum free condition. After 24 h of transfection, 3 Â serum was added and kept for another 36 h. The cells were lysed and used for immunoblot analysis. Protein levels of HDAC-6, HDAC-2, claudin-1 and actin were determined by western blot. Blots shown are representative of three independent experiments.
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